Literature DB >> 1986677

The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda.

P P Eriki1, A Okwera, T Aisu, A B Morrissey, J J Ellner, T M Daniel.   

Abstract

The clinical, radiographic, and microbiologic features of 59 patients with pulmonary tuberculosis in Kampala, Uganda were studied and correlated with the serologic reactivity to the human immunodeficiency virus (HIV) of these patients. Two-thirds of the patients with tuberculosis were HIV-seropositive. Histories of fever and weight loss were more prominent in HIV-seropositive patients, and perihilar and basilar infiltrative diseases were more frequently seen in HIV-seropositive patients. Although all patients responded similarly to drug therapy, cutaneous drug reactions were seen in nearly one-third of HIV-seropositive patients receiving thiacetazone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1986677     DOI: 10.1164/ajrccm/143.1.185

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

1.  Public and private providers' quality of care for tuberculosis patients in Kampala, Uganda.

Authors:  L Nshuti; D Neuhauser; J L Johnson; F Adatu; C C Whalen
Journal:  Int J Tuberc Lung Dis       Date:  2001-11       Impact factor: 2.373

2.  Efficacy of an unsupervised 8-month rifampicin-containing regimen for the treatment of pulmonary tuberculosis in HIV-infected adults. Uganda-Case Western Reserve University Research Collaboration.

Authors:  J L Johnson; A Okwera; P Nsubuga; J G Nakibali; C C Whalen; D Hom; M D Cave; Z H Yang; R D Mugerwa; J J Ellner
Journal:  Int J Tuberc Lung Dis       Date:  2000-11       Impact factor: 2.373

3.  Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis.

Authors:  Alphonse Okwera; David K Mafigiri; David Guwatudde; Christopher Whalen; Moses Joloba
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

Review 4.  AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

Review 5.  HIV: treating tuberculosis.

Authors:  Brendan Payne; Richard Bellamy
Journal:  BMJ Clin Evid       Date:  2009-11-05

6.  Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis.

Authors:  Simon J Tsiouris; David Coetzee; Patricia L Toro; Judy Austin; Zena Stein; Wafaa El-Sadr
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 7.  Tropical respiratory medicine. 2. Impact of human immunodeficiency virus on tuberculosis in developing countries.

Authors:  P P Nunn; A M Elliott; K P McAdam
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139

Review 8.  An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa.

Authors:  A D Harries; D Maher; P Nunn
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

9.  Interferon-gamma and tumour necrosis factor-alpha production by CD4+ T and CD8+ T lymphocytes in AIDS patients with tuberculosis.

Authors:  R M de Castro Cunha; E G Kallas; D S Rodrigues; M Nascimento Burattini; R Salomao
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

10.  Lay workers in directly observed treatment (DOT) programmes for tuberculosis in high burden settings: Should they be paid? A review of behavioural perspectives.

Authors:  Samson Kironde; Francis Bajunirwe
Journal:  Afr Health Sci       Date:  2002-08       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.